VanEck Biotech ETF (BBH) is an exchange-traded fund in the Health category. It has $395.55M in assets, an expense ratio of 0.35% and a 0.47% dividend yield. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Assets under management
$395.55M
Expense ratio
0.35%
Category
Health
Dividend yield
0.47%
NAV
$204.31
Fund family
VanEck
Exchange
NASDAQ
Top holdings
The largest positions VanEck Biotech ETF reports, by weight.